CAR-T cell therapy embarks on autoimmune disease

1

CD19CAR-T therapy has shown effectiveness in treating autoimmune diseases, particularly in patients who are refractory to B-cell targeting monoclonal antibodies.
2

In a study, CD19CAR-T therapy was safe and led to significant improvements in disease activity scores in patients with systemic lupus erythematosus.
3

CD19CAR-T therapy resulted in transient B-cell aplasia, which may serve a therapeutic role in antibody-mediated autoimmune diseases.
4

Initial trials of BCMA-targeting CAR-T cells demonstrated significant reductions in disease activity and improvements in renal function in lupus patients.
5

CAR-T therapy is being explored for neurological conditions like myasthenia gravis and multiple sclerosis, showing promising safety and efficacy results.

Bone Marrow Transplantation

1